ArticleCureus2025
Complete Recovery From Human Herpesvirus 6 (HHV-6) Encephalomyelitis in an Immunocompetent Adult: A Rare Cause of Paraparesis and Ataxia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human herpesvirus 6 (HHV-6) is a commonly acquired virus in early childhood, typically resulting in a benign and self-limited illness. However, its neuroinvasive potential in adults, particularly in immunocompetent individuals, remains underrecognized and diagnostically challenging. Clinical features such as nonspecific fever, respiratory symptoms, and evolving neurological deficits can mimic autoimmune demyelination, post-infectious encephalitis, or other viral myelitides, potentially delaying recognition and treatment. We report the case of a previously healthy 32-year-old male who presented with fever, lower respiratory symptoms, and progressive neurological deficits, including lower limb weakness, gait instability, and sensory abnormalities suggestive of spinal cord involvement. Initial imaging was inconclusive, but cerebrospinal fluid analysis revealed lymphocytic pleocytosis, elevated protein, and was positive for HHV-6 by Polymerase Chain Reaction (PCR). The patient was treated with intravenous ganciclovir and immunoglobulin, leading to clinical improvement and viral clearance. This case highlights the importance of considering HHV-6 in the differential diagnosis of acute encephalomyelitis, even in immunocompetent adults, and demonstrates that early antiviral and immunomodulatory therapy can lead to favorable neurological outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.